Exposure to perflubron is associated with decreased Syk phosphorylation in human neutrophils.
D001665:Binding Sites; D002465:Cell Movement / Q000187:drug effects; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D004792:Enzyme Precursors / Q000378:metabolism*; D005466:Fluorocarbons / Q000494:pharmacology*; D006801:Humans; D006842:Hydrocarbons, Brominated; D015151:Immunoblotting; D066298:In Vitro Techniques; D047908:Intracellular Signaling Peptides and Proteins; D021061:Liquid Ventilation / Q000009:adverse effects*; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000378:metabolism; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D010587:Phagocytosis / Q000187:drug effects; D010766:Phosphorylation; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D015290:Second Messenger Systems / Q000187:drug effects; D000072377:Syk Kinase; D014443:Tyrosine / Q000378:metabolism